How to Buy Whitehawk Therapeutics Stock
Whitehawk Therapeutics Inc
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles. .
Whitehawk Therapeutics stock last closed at $4.10, down 1.44% from the previous day, and has increased 100.98% in one year. It has overperformed other stocks in the Biotechnology industry by 1.73 percentage points. Whitehawk Therapeutics stock is currently +161.15% from its 52-week low of $1.57, and -25.39% from its 52-week high of $5.50.
There are currently 49.45M WHWK shares outstanding. The market capitalization of WHWK is $202.76M. In the last 24 hours, 254,000 WHWK shares were traded.
How to Buy Whitehawk Therapeutics Stock
Wondering how to invest in Whitehawk Therapeutics stock? Here's how.
- Choose where to buy Whitehawk Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Whitehawk Therapeutics stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your method of payment and add your details.
- Evaluate Whitehawk Therapeutics stock: The Whitehawk Therapeutics ticker symbol is WHWK. Is Whitehawk Therapeutics stock a good investment? Should you buy shares of WHWK? How do WHWK's underlying business fundamentals look? Do top analysts think Whitehawk Therapeutics is a good buy? Why has WHWK's stock price moved recently? (Hint: Our stock market research tools can help you understand if WHWK is a good stock to buy).
- Execute your WHWK buy order: Decide if you will purchase WHWK shares at the current market price or use a limit order to buy WHWK shares at a given price.
- Get updates on your WHWK position: Create a watchlist to important updates regarding your position in Whitehawk Therapeutics stock.
Step 1: Choose where to buy Whitehawk Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy WHWK shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you can buy WHWK today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open your new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on mobile trading apps, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your new investment account.
Step 4: Evaluate Whitehawk Therapeutics stock
Once you have selected the best place to buy Whitehawk Therapeutics stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and upside.
Whitehawk Therapeutics quick stats
WHWK Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on WHWK's stock page.
Is WHWK stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge WHWK's fair value.
Using relative valuations metrics:
- WHWK could be undervalued based on its P/B ratio of 1.75x, relative to Biotechnology industry P/B ratio of 4.89x
You can access more valuation analysis on WHWK's stock here.
How do WHWK Financials look?
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the WHWK balance sheet.
- WHWK has cash burn of 107778000. It has enough cash and short-term investments to cover this for at least one year.
- WHWK has a low debt to equity ratio of 0.1.
- There are more short-term assets than short-term liabilities on the WHWK balance sheet.
Failed Health Checks:
- WHWK has $123.04M in cash and short term investments. This is not sufficient to cover its annual cash burn of $107.78M.
- Total WHWK debt is higher than 5 years ago, relative to shareholder equity.
Is Whitehawk Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 sell side analysts who track WHWK, the consensus analyst rating on Whitehawk Therapeutics is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Whitehawk Therapeutics stock forecast page.
WHWK Trading Indicators
Is WHWK Making Money?
Last year, WHWK revenue was $0.00. During the last 5 year, WHWK's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 32.3%.
You can analyze WHWK's earnings and revenue performance here.
Are WHWK insiders buying or selling the stock?
In the last 12 months, insiders at WHWK have sold more shares than they have bought.
Bryan Ball, Chief Technical Operations Officer of WHWK, was the latest WHWK insider to buy. They bought $199,998.40 worth of WHWK shares on May 14, 2026.
Research more about who owns WHWK shares here.
Does WHWK stock generate passive income?
No, Whitehawk Therapeutics doesn't provide an income stream by paying out dividends.
WHWK Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your WHWK buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open button and your broker will place the order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your WHWK position
Now that you own some shares in WHWK, you'll want to keep up with your new stock purchase.
Create a watchlist to keep track of your WHWK stock.
WHWK Feed
How to Buy Stock in Whitehawk Therapeutics
To reiterate, here are the 6 steps for buying Whitehawk Therapeutics stock:
- Choose where to buy Whitehawk Therapeutics stock
- Open your brokerage account
- Put funds into your brokerage account
- Evaluate Whitehawk Therapeutics stock
- Execute your WHWK buy order
- Get updates on your WHWK position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Whitehawk Therapeutics, click below.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.